Cardlytics
CDLX
127 hedge funds and large institutions have $288M invested in Cardlytics in 2024 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 49 increasing their positions, 37 reducing their positions, and 36 closing their positions.
32% more repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 37
20% more call options, than puts
Call options by funds: $11.6M | Put options by funds: $9.65M
1.15% less ownership
Funds ownership: 8.08% → 6.93% (-1.2%)
11% less funds holding in top 10
Funds holding in top 10: 9 → 8 (-1)
12% less funds holding
Funds holding: 144 → 127 (-17)
44% less capital invested
Capital invested by funds: $516M → $288M (-$227M)
47% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 36
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Brightlight Capital Management
Westport,
Connecticut
|
+$6.54M |
| 2 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$3.46M |
| 3 |
Renaissance Technologies
New York
|
+$3.33M |
| 4 |
BlackRock
New York
|
+$3.04M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.17M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$6.71M |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$6.49M |
| 3 |
D.E. Shaw & Co
New York
|
-$4.49M |
| 4 |
KLC
Kent Lake Capital
Reno,
Nevada
|
-$3.62M |
| 5 |
PIP
PB Investment Partners
Burlingame,
California
|
-$3.23M |
CDLX Hedge Fund Activity: Q2 2024 in Review
127 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Cardlytics (CDLX) for Q2 2024, worth a combined $288M — down 44% from $516M a quarter earlier.
Sellers outnumbered buyers: 36 funds closed out of CDLX and 19 opened new positions — a net loss of 17 holders — while 37 trimmed existing stakes and 49 added.
The largest buyer was Brightlight Capital Management, adding an estimated $6.54M. The largest seller was Invesco, cutting an estimated $6.71M.
- 127 institutional investors held Cardlytics (CDLX) as of Q2 2024, down from 144 in Q1 2024.
- Funds reported $288M of Cardlytics stock for Q2 2024, down 44% quarter-over-quarter.
- 19 funds opened new Cardlytics positions in Q2 2024 and 36 closed out, a net change of -17 holders.
- The largest Cardlytics buyer in Q2 2024 was Brightlight Capital Management, an estimated $6.54M added.
- The largest Cardlytics seller in Q2 2024 was Invesco, an estimated $6.71M sold.
Based on aggregated 13F filings for Q2 2024.